PHIO
Price
$2.22
Change
+$0.18 (+8.82%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
11.99M
ZVSA
Price
$0.72
Change
+$0.01 (+1.41%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
1.67M
Ad is loading...

PHIO vs ZVSA

Header iconPHIO vs ZVSA Comparison
Open Charts PHIO vs ZVSABanner chart's image
Phio Pharmaceuticals
Price$2.22
Change+$0.18 (+8.82%)
Volume$3.77K
Capitalization11.99M
ZyVersa Therapeutics
Price$0.72
Change+$0.01 (+1.41%)
Volume$100
Capitalization1.67M
PHIO vs ZVSA Comparison Chart
Loading...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZVSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PHIO vs. ZVSA commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHIO is a Buy and ZVSA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (PHIO: $2.05 vs. ZVSA: $0.71)
Brand notoriety: PHIO and ZVSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHIO: 25% vs. ZVSA: 3%
Market capitalization -- PHIO: $11.99M vs. ZVSA: $1.67M
PHIO [@Biotechnology] is valued at $11.99M. ZVSA’s [@Biotechnology] market capitalization is $1.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHIO’s FA Score shows that 0 FA rating(s) are green whileZVSA’s FA Score has 1 green FA rating(s).

  • PHIO’s FA Score: 0 green, 5 red.
  • ZVSA’s FA Score: 1 green, 4 red.
According to our system of comparison, PHIO is a better buy in the long-term than ZVSA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHIO’s TA Score shows that 5 TA indicator(s) are bullish while ZVSA’s TA Score has 3 bullish TA indicator(s).

  • PHIO’s TA Score: 5 bullish, 5 bearish.
  • ZVSA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, PHIO is a better buy in the short-term than ZVSA.

Price Growth

PHIO (@Biotechnology) experienced а -24.07% price change this week, while ZVSA (@Biotechnology) price change was -0.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

PHIO is expected to report earnings on Mar 31, 2025.

ZVSA is expected to report earnings on Apr 12, 2023.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHIO($12M) has a higher market cap than ZVSA($1.67M). PHIO has higher P/E ratio than ZVSA: PHIO (0.01) vs ZVSA (0.00). PHIO YTD gains are higher at: 13.889 vs. ZVSA (-33.208). PHIO has higher annual earnings (EBITDA): -7.41M vs. ZVSA (-9.62M). PHIO has more cash in the bank: 5.39M vs. ZVSA (123K). PHIO (0) and ZVSA (0) have identical debt. PHIO (0) and ZVSA (0) have equivalent revenues.
PHIOZVSAPHIO / ZVSA
Capitalization12M1.67M719%
EBITDA-7.41M-9.62M77%
Gain YTD13.889-33.208-42%
P/E Ratio0.010.00964%
Revenue00-
Total Cash5.39M123K4,382%
Total Debt00-
FUNDAMENTALS RATINGS
PHIO: Fundamental Ratings
PHIO
OUTLOOK RATING
1..100
40
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
56
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PHIOZVSA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
61%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 21 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
63%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZVSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HSIC65.490.95
+1.47%
Henry Schein
CPAC5.470.01
+0.18%
Cementos Pacasmayo SAA
NB2.59N/A
N/A
NioCorp Developments Ltd
RNW6.34-0.09
-1.40%
ReNew Energy Global plc
SXTC1.70-0.39
-18.51%
China SXT Pharmaceuticals Inc.

PHIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHIO has been loosely correlated with MTNB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PHIO jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHIO
1D Price
Change %
PHIO100%
-18.33%
MTNB - PHIO
50%
Loosely correlated
-2.48%
TPST - PHIO
49%
Loosely correlated
+4.09%
BPMC - PHIO
40%
Loosely correlated
+2.81%
IMNN - PHIO
39%
Loosely correlated
-1.34%
SAGE - PHIO
38%
Loosely correlated
-0.78%
More

ZVSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZVSA has been loosely correlated with CGEM. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ZVSA jumps, then CGEM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZVSA
1D Price
Change %
ZVSA100%
+6.47%
CGEM - ZVSA
34%
Loosely correlated
+0.12%
PHIO - ZVSA
29%
Poorly correlated
-18.33%
SYRE - ZVSA
28%
Poorly correlated
+1.86%
REVB - ZVSA
28%
Poorly correlated
-10.92%
ANVS - ZVSA
26%
Poorly correlated
+2.72%
More